zolmitriptan nasal spray 2.5 and 5mg provided equivalent systemic exposure to that of oral tablets. Zolmitriptan was more rapidly absorbed following intranasal than oral administration and was ...

rhinitis and chronic sinusitis); although another study subsequently found that the presence of rhinitis did not affect the efficacy and tolerability of zolmitriptan nasal spray, [12] this had not ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...